Skip to main content
CH

Cyted Health

Cyted utilizes artificial intelligence and digital pathology to enhance the detection of upper gastrointestinal diseases, including pre-cancerous conditions. Their non-endoscopic diagnostic platform, EndoSign®, enables earlier diagnosis and improved access to care for millions affected by these conditions globally.

United KingdomFounded 2020653K+ followers
Updated 20 months ago

Funding

Funding not disclosed

MI
Funding rounds are not available yet.

Founders

Product

Problem

Upper gastrointestinal diseases, including pre-cancerous conditions like Barrett's esophagus, affect a significant portion of the global population, often leading to delayed diagnoses due to reliance on traditional endoscopic procedures. Traditional gastroscopies can have long waiting times, limited availability, and may require sedation, creating barriers to timely detection and monitoring.

Solution

Cyted Health offers EndoSign®, a non-endoscopic diagnostic platform that enhances the detection and monitoring of upper gastrointestinal diseases. EndoSign® utilizes a capsule sponge test, a less invasive alternative to traditional endoscopy, where patients swallow a capsule containing a sponge that collects cell samples for analysis as it is being extracted. This approach enables earlier diagnosis of conditions like Barrett’s esophagus, a known risk factor for esophageal cancer, and improves access to care by reducing waiting times and expanding testing availability outside of hospital settings. The platform aims to transform digestive health by facilitating earlier and faster diagnoses, ultimately improving patient outcomes and reducing the risk of late-stage disease detection.

Target Audience

The primary target audience includes healthcare providers such as gastroenterologists, hospitals, and community healthcare services seeking to improve early detection rates and access to diagnostics for upper gastrointestinal diseases, as well as patients with gastro-oesophageal reflux disease symptoms.

Features

  • Capsule sponge technology for cell sample collection as an alternative to traditional endoscopy
  • Nurse-led diagnostic pathway enabling testing outside of hospital settings
  • Reduced patient waiting times for diagnosis
  • Electronic forms to improve the speed and accuracy of patient selection
  • Upskilling opportunities for nurses, improving career pathways and staff retention
  • Cost reduction compared to gastroscopy due to skill mix, setting, and product
This profile is AI-generated and may contain inaccuracies.